ArticleCells2020

PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.

Sandra Muñoz-Galván et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.